author_facet Behets, F
Disasi, A
Ryder, R W
Bishagara, K
Piot, P
Kashamuka, M
Kamenga, M
Nzila, N
Laga, M
Vercauteren, G
Behets, F
Disasi, A
Ryder, R W
Bishagara, K
Piot, P
Kashamuka, M
Kamenga, M
Nzila, N
Laga, M
Vercauteren, G
author Behets, F
Disasi, A
Ryder, R W
Bishagara, K
Piot, P
Kashamuka, M
Kamenga, M
Nzila, N
Laga, M
Vercauteren, G
spellingShingle Behets, F
Disasi, A
Ryder, R W
Bishagara, K
Piot, P
Kashamuka, M
Kamenga, M
Nzila, N
Laga, M
Vercauteren, G
Journal of Clinical Microbiology
Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
Microbiology (medical)
author_sort behets, f
spelling Behets, F Disasi, A Ryder, R W Bishagara, K Piot, P Kashamuka, M Kamenga, M Nzila, N Laga, M Vercauteren, G 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.29.10.2280-2284.1991 <jats:p>Detection by five different enzyme-linked immunosorbent assays (ELISAs) of antibody to human immunodeficiency virus (HIV) in sera from three Zairian populations consisting of 1,998 individuals with various risks for HIV infection was evaluated. Sera that were reactive by at least one assay and 10% of the nonreactive serum samples were analyzed by Western blot (immunoblot) by using U.S. Public Health Service interpretation criteria. Sera which were positive by ELISA for detection of antibody to HIV-1 and HIV-2 and negative or indeterminate by HIV-1 Western blot were also analyzed by HIV-2 Western blot. Overall, 443 (22.2%) serum specimens were HIV-1 Western blot positive, 390 (19.5%) had indeterminate HIV-1 Western blot patterns, and no samples were HIV-2 Western blot positive. The sensitivity of the ELISAs ranged from 97.5 to 99.8%, and the specificity ranged from 51.7 to 98.4%. By population group, the negative predictive value ranged from 97.1 to 100%, in contrast to the positive predictive value, which varied from 6.6 to 100%. Follow-up results for sera which were indeterminate for antibody to HIV-1 documented only four seroconversions (6.0%) among 67 individuals at high risk for HIV-1 infection and no seroconversions among 202 individuals at relatively low risk for HIV-1 infection. This study demonstrates the importance of evaluating commercial ELISAs with sera from appropriate geographical regions in order to select the most cost-effective and practical assay for use in that region. Furthermore, the high frequency of indeterminate Western blots for African sera emphasizes the continual need for improved confirmatory assays and interpretation criteria.</jats:p> Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa Journal of Clinical Microbiology
doi_str_mv 10.1128/jcm.29.10.2280-2284.1991
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMjkuMTAuMjI4MC0yMjg0LjE5OTE
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMjkuMTAuMjI4MC0yMjg0LjE5OTE
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint American Society for Microbiology, 1991
imprint_str_mv American Society for Microbiology, 1991
issn 0095-1137
1098-660X
issn_str_mv 0095-1137
1098-660X
language English
mega_collection American Society for Microbiology (CrossRef)
match_str behets1991comparisonoffivecommercialenzymelinkedimmunosorbentassaysandwesternimmunoblottingforhumanimmunodeficiencyvirusantibodydetectioninserumsamplesfromcentralafrica
publishDateSort 1991
publisher American Society for Microbiology
recordtype ai
record_format ai
series Journal of Clinical Microbiology
source_id 49
title Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_unstemmed Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_full Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_fullStr Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_full_unstemmed Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_short Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_sort comparison of five commercial enzyme-linked immunosorbent assays and western immunoblotting for human immunodeficiency virus antibody detection in serum samples from central africa
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.29.10.2280-2284.1991
publishDate 1991
physical 2280-2284
description <jats:p>Detection by five different enzyme-linked immunosorbent assays (ELISAs) of antibody to human immunodeficiency virus (HIV) in sera from three Zairian populations consisting of 1,998 individuals with various risks for HIV infection was evaluated. Sera that were reactive by at least one assay and 10% of the nonreactive serum samples were analyzed by Western blot (immunoblot) by using U.S. Public Health Service interpretation criteria. Sera which were positive by ELISA for detection of antibody to HIV-1 and HIV-2 and negative or indeterminate by HIV-1 Western blot were also analyzed by HIV-2 Western blot. Overall, 443 (22.2%) serum specimens were HIV-1 Western blot positive, 390 (19.5%) had indeterminate HIV-1 Western blot patterns, and no samples were HIV-2 Western blot positive. The sensitivity of the ELISAs ranged from 97.5 to 99.8%, and the specificity ranged from 51.7 to 98.4%. By population group, the negative predictive value ranged from 97.1 to 100%, in contrast to the positive predictive value, which varied from 6.6 to 100%. Follow-up results for sera which were indeterminate for antibody to HIV-1 documented only four seroconversions (6.0%) among 67 individuals at high risk for HIV-1 infection and no seroconversions among 202 individuals at relatively low risk for HIV-1 infection. This study demonstrates the importance of evaluating commercial ELISAs with sera from appropriate geographical regions in order to select the most cost-effective and practical assay for use in that region. Furthermore, the high frequency of indeterminate Western blots for African sera emphasizes the continual need for improved confirmatory assays and interpretation criteria.</jats:p>
container_issue 10
container_start_page 2280
container_title Journal of Clinical Microbiology
container_volume 29
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792336747834638348
geogr_code not assigned
last_indexed 2024-03-01T15:05:22.341Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Comparison+of+five+commercial+enzyme-linked+immunosorbent+assays+and+Western+immunoblotting+for+human+immunodeficiency+virus+antibody+detection+in+serum+samples+from+Central+Africa&rft.date=1991-10-01&genre=article&issn=1098-660X&volume=29&issue=10&spage=2280&epage=2284&pages=2280-2284&jtitle=Journal+of+Clinical+Microbiology&atitle=Comparison+of+five+commercial+enzyme-linked+immunosorbent+assays+and+Western+immunoblotting+for+human+immunodeficiency+virus+antibody+detection+in+serum+samples+from+Central+Africa&aulast=Vercauteren&aufirst=G&rft_id=info%3Adoi%2F10.1128%2Fjcm.29.10.2280-2284.1991&rft.language%5B0%5D=eng
SOLR
_version_ 1792336747834638348
author Behets, F, Disasi, A, Ryder, R W, Bishagara, K, Piot, P, Kashamuka, M, Kamenga, M, Nzila, N, Laga, M, Vercauteren, G
author_facet Behets, F, Disasi, A, Ryder, R W, Bishagara, K, Piot, P, Kashamuka, M, Kamenga, M, Nzila, N, Laga, M, Vercauteren, G, Behets, F, Disasi, A, Ryder, R W, Bishagara, K, Piot, P, Kashamuka, M, Kamenga, M, Nzila, N, Laga, M, Vercauteren, G
author_sort behets, f
container_issue 10
container_start_page 2280
container_title Journal of Clinical Microbiology
container_volume 29
description <jats:p>Detection by five different enzyme-linked immunosorbent assays (ELISAs) of antibody to human immunodeficiency virus (HIV) in sera from three Zairian populations consisting of 1,998 individuals with various risks for HIV infection was evaluated. Sera that were reactive by at least one assay and 10% of the nonreactive serum samples were analyzed by Western blot (immunoblot) by using U.S. Public Health Service interpretation criteria. Sera which were positive by ELISA for detection of antibody to HIV-1 and HIV-2 and negative or indeterminate by HIV-1 Western blot were also analyzed by HIV-2 Western blot. Overall, 443 (22.2%) serum specimens were HIV-1 Western blot positive, 390 (19.5%) had indeterminate HIV-1 Western blot patterns, and no samples were HIV-2 Western blot positive. The sensitivity of the ELISAs ranged from 97.5 to 99.8%, and the specificity ranged from 51.7 to 98.4%. By population group, the negative predictive value ranged from 97.1 to 100%, in contrast to the positive predictive value, which varied from 6.6 to 100%. Follow-up results for sera which were indeterminate for antibody to HIV-1 documented only four seroconversions (6.0%) among 67 individuals at high risk for HIV-1 infection and no seroconversions among 202 individuals at relatively low risk for HIV-1 infection. This study demonstrates the importance of evaluating commercial ELISAs with sera from appropriate geographical regions in order to select the most cost-effective and practical assay for use in that region. Furthermore, the high frequency of indeterminate Western blots for African sera emphasizes the continual need for improved confirmatory assays and interpretation criteria.</jats:p>
doi_str_mv 10.1128/jcm.29.10.2280-2284.1991
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9qY20uMjkuMTAuMjI4MC0yMjg0LjE5OTE
imprint American Society for Microbiology, 1991
imprint_str_mv American Society for Microbiology, 1991
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 0095-1137, 1098-660X
issn_str_mv 0095-1137, 1098-660X
language English
last_indexed 2024-03-01T15:05:22.341Z
match_str behets1991comparisonoffivecommercialenzymelinkedimmunosorbentassaysandwesternimmunoblottingforhumanimmunodeficiencyvirusantibodydetectioninserumsamplesfromcentralafrica
mega_collection American Society for Microbiology (CrossRef)
physical 2280-2284
publishDate 1991
publishDateSort 1991
publisher American Society for Microbiology
record_format ai
recordtype ai
series Journal of Clinical Microbiology
source_id 49
spelling Behets, F Disasi, A Ryder, R W Bishagara, K Piot, P Kashamuka, M Kamenga, M Nzila, N Laga, M Vercauteren, G 0095-1137 1098-660X American Society for Microbiology Microbiology (medical) http://dx.doi.org/10.1128/jcm.29.10.2280-2284.1991 <jats:p>Detection by five different enzyme-linked immunosorbent assays (ELISAs) of antibody to human immunodeficiency virus (HIV) in sera from three Zairian populations consisting of 1,998 individuals with various risks for HIV infection was evaluated. Sera that were reactive by at least one assay and 10% of the nonreactive serum samples were analyzed by Western blot (immunoblot) by using U.S. Public Health Service interpretation criteria. Sera which were positive by ELISA for detection of antibody to HIV-1 and HIV-2 and negative or indeterminate by HIV-1 Western blot were also analyzed by HIV-2 Western blot. Overall, 443 (22.2%) serum specimens were HIV-1 Western blot positive, 390 (19.5%) had indeterminate HIV-1 Western blot patterns, and no samples were HIV-2 Western blot positive. The sensitivity of the ELISAs ranged from 97.5 to 99.8%, and the specificity ranged from 51.7 to 98.4%. By population group, the negative predictive value ranged from 97.1 to 100%, in contrast to the positive predictive value, which varied from 6.6 to 100%. Follow-up results for sera which were indeterminate for antibody to HIV-1 documented only four seroconversions (6.0%) among 67 individuals at high risk for HIV-1 infection and no seroconversions among 202 individuals at relatively low risk for HIV-1 infection. This study demonstrates the importance of evaluating commercial ELISAs with sera from appropriate geographical regions in order to select the most cost-effective and practical assay for use in that region. Furthermore, the high frequency of indeterminate Western blots for African sera emphasizes the continual need for improved confirmatory assays and interpretation criteria.</jats:p> Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa Journal of Clinical Microbiology
spellingShingle Behets, F, Disasi, A, Ryder, R W, Bishagara, K, Piot, P, Kashamuka, M, Kamenga, M, Nzila, N, Laga, M, Vercauteren, G, Journal of Clinical Microbiology, Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa, Microbiology (medical)
title Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_full Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_fullStr Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_full_unstemmed Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_short Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
title_sort comparison of five commercial enzyme-linked immunosorbent assays and western immunoblotting for human immunodeficiency virus antibody detection in serum samples from central africa
title_unstemmed Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa
topic Microbiology (medical)
url http://dx.doi.org/10.1128/jcm.29.10.2280-2284.1991